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Edited by AO AremuMedicinal plants are considered to be amajor source of biologically active compounds, which provides unlimited
opportunities for their use either as medical treatments or as novel drug formulations.
The focus of our study was on basic phytochemical analysis and in vitro examination of the biological activity of
Alchemilla vulgaris L. Methanolic extracts of above ground parts and roots of A. vulgaris (AVA and AVR, respec-
tively) were prepared by maceration for 72 h. Phytochemical proﬁle of extracts was evaluated by spectrophoto-
metric determinations of phenolic compounds and HPLC-PDA analysis. AVA and AVR were analysed for their
antioxidant efﬁcacy as total antioxidant capacity, metal chelation and reducing power ability, inhibition of lipid
peroxidation as well as their potential to neutralise DPPH, ABTS, and OH radicals. Microdilution method was
employed to investigate the antibacterial and antifungal activity of extracts against nine ATCC and isolates of
bacteria and ten fungal strains from biological samples. Anti-inﬂammatory activity of the extracts was evaluated
using cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) assays and the assay for determination of COX-2
gene expression, while biocompatibility of extracts was assessed by MTT assay.
Our results revealed the high amount of phenolic compounds in both extracts; especially they were rich in
condensed tannins. Ellagic acid and catechin were tentatively identiﬁed in AVA and AVR, respectively. Full
biocompatibility as well as remarkable bioactivity were observed for both extracts in all employed assays, so
our further investigations will be focused on the identiﬁcation of active constituents in A. vulgaris and themolec-
ular mechanisms of their action.
© 2018 SAAB. Published by Elsevier B.V. All rights reserved.Keywords:
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Several lines of evidence support the hypothesis that secondary
metabolites from plants (e.g. ﬂavonoids and phenolic acids) may play
an antioxidant role and diminish the adverse effects of an imbalance
between the production of enzymatic and non-enzymatic antioxidants
and overproduction of free radicals in oxidative stress (Hussein and
Khalifa, 2014). As a result of their antioxidant activity, either through
their reducing capacity or through potential inﬂuences on intracellular
redox processes, phenolic compounds manifest various beneﬁcialthanolic extract; AVR, Alchemilla
ecies; COX-1, cyclooxygenase-1;
NSAIDs, non-steroidal anti-
is factor α; iNOS, inducible nitric
in-enhancer of activated B cells;
hts reserved.effects, including anti-inﬂammatory and anticancerogenic activities
(Han et al., 2007; Li et al., 2014).
Alchemilla vulgaris L. (Lady's mantle), an herbaceous perennial plant
belonging to the Rosaceae family, is widely spread across Europe and
Asia and commonly known in traditional medicine for treatment of
ulcers, wounds, eczema, and digestive problems as well as a remedy for
gynaecological disorders, such as heavy menstrual ﬂow, menorrhagia
and dysmenorrhoea (Jarić et al., 2015; Masullo et al., 2015;
Ilić-Stojanović et al., 2017). Alchemilla species have been reported to
exert a variety of biological activities, including antiviral, antioxidant,
antiproliferative, and antibacterial activity as well as healing effects on
cutaneous wounds in rats (Trouillas et al., 2003; Shrivastava and John,
2006; Filippova, 2017). Previous ﬁndings showed that aerial parts of
A. vulgaris comprise mostly phenolic compounds – a large amount of
tannins, phenolic acids (predominantly ellagic acid, gallic, and caffeic
acids), ﬂavonoids (quercetin), and ﬂavonoid glycosides (isoquercetin,
rutin, avicularin, and tiliroside) (Møller et al., 2009). To the extent of
our knowledge, there is a scarce literature on phytochemical proﬁle and
biological activity of roots of A. vulgaris.
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molecules triggering a multitude of ailments, such as rheumatoid
arthritis, cardiovascular disorders, neurological disease, and cancer
(Hitchon and El-Gabalawy, 2004; Valko et al., 2004; Melo et al., 2011).
Increased ROS generation has been described as one of the key factors
in the progression of inﬂammatory disorders (Mittal et al., 2014).
Cyclooxygenases (COX-1 and COX-2) are enzymes involved in the
inﬂammatory process and responsible for the conversion of arachidonic
acid into pro-inﬂammatory mediators, like prostaglandin H2 (PGH2).
COX-1 is a constitutive enzyme expressed in almost all cells providing
homeostatic functions. Under normal conditions, COX-2 is unexpressed
in most cells, but its expression can be induced by inﬂammatory stimuli.
Hence, COX-2 is amajor target for anti-inﬂammatory therapies. Since the
use of non-selective COX inhibitors (non-steroidal anti-inﬂammatory
drugs-NSAIDs) may lead to side effects, particularly evident in the
gastrointestinal tract (Jones et al., 2008), novel COX-2-speciﬁc agents,
with no or very little undesirable effects, are urgently needed.
The presented study was focused on assessment of biocompatibility,
antioxidant, antimicrobial, and anti-inﬂammatory activities of methano-
lic extracts of aerial parts and roots of Lady's mantle (A. vulgaris) and
their phytochemical proﬁle as well.
2. Materials and methods
2.1. Chemicals and instruments
All spectrophotometric determinations were performed on UV–Vis
double beam spectrophotometer Halo DB-20S (Dynamica GmbH,
Dietikon, Switzerland). Ellagic acid, hyperoside, rutin and TRIS/HCl-
buffer were obtained from Carl Roth (Karlruhe, Germany), trolox,
epicatechin, catechin, gallic acid, vanillic acid, rutin, kaempferol, querce-
tin, DMSO (N99.98% purity), and formic acid from Sigma-Aldrich
(Deisenhofen, Germany), caffeic acid and Na2EDTA (Titriplex III) from
Merck KGaA (Darmstadt, Germany). HPLC-grade acetonitrile, water,
and triﬂuoroacetic acid were purchased from Merck (Darmstadt,
Germany). Resazurin was purchased from Acros Organics (Geel,
Belgium), while all other chemicals used in antimicrobial experiments
were purchased from Torlak Institute of Virology, Vaccines, and Sera
(Belgrade, Serbia). Reagents used in COX-1 and -2 assays: puriﬁed
prostaglandin H synthase (PGHS)-1 from ram seminal vesicles, human
recombinant PGHS-2, NS-398, and arachidonic acid were obtained
from Cayman Chemical Co. (Ann Arbor, MI, USA), hematin (porcine)
and indomethacin from ICN (Aurora, Ohio, USA), epinephrine hydrogen
tartarate from Fluka (Buchs, Switzerland), and competitive PGE2 EIA kit
from Assay Designs Inc. (Ann Arbor, MI, USA). COX-2 gene expression
kits, reagents and chemicals for this method: fetal bovine serum (FBS),
N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES), phos-
phate buffered saline (PBS), penicillin, and streptomycin human
leukemicmonocytic cell line THP-1 (European Collection of Cell Culture;
Item No. 88081201), and RPMI1640 were obtained from Gibco® (NY,
USA), phorbol 12-myristate 13-acetate (PMA), while dexamethasone,
lipopolysaccharide (LPS) as well as GenElute™ Mammalian TotalRNA
Miniprep Kit were from Sigma-Aldrich (MO, USA). High-Capacity
cDNA Reverse Transcription Kit, Pre-developed TaqMan® Assay,
COX-2 primers and COX-2 probe were from Applied Biosystems (NY,
USA). BalbC-3 T3 ﬁbroblasts (clone A31) were purchased from ATCC
(Manassas, VA) and human epidermal keratinocytes (HaCaT) from
Innoprot (Biscay, Spain).
2.2. Plant material and preparation of the extracts
The roots and aerial parts of Alchemilla vulgaris L. were collected in
August 2014 at Goč Mountain (Central Serbia). Collection of plant
material was carried out by the sampling of 20 representative indi-
viduals of the population in the full ﬂowering period. The taxonomic
and botanical identity was conﬁrmed by Milan Stanković, PhD. Avoucher specimen (No. 120/015) is kept in the Herbarium of the
Department of Biology and Ecology, Faculty of Science, University of
Kragujevac, Kragujevac, Serbia. The collected plants were air-dried in
darkness at ambient temperature. The dried aerial parts and roots
separately from all individuals were cut up, mixed and powdered for
extracts preparation.
Dried and powdered aerial parts (30.00 g) and roots (55.80 g) of
A. vulgaris were macerated with methanol (150 and 280 mL, respec-
tively) for 24 h three times, by continuous stirring at room temperature.
Mass of the extracts was determined after ﬁltration through Whatman
No.1 ﬁlter paper and concentrating under reduced pressure at 45 °C.
The obtained dry weights of the extracts were 3.70 g for A. vulgaris aerial
parts (AVA) and 9.00 g for roots (AVR), (12% w/w and 16.13% w/w,
respectively). The obtained extracts were kept at+4 °C until further use.
2.3. Chromatographic analysis
The identiﬁcation of individual phenolic compounds in the extracts
was performed using HPLC system (Shimadzu Prominence, Kyoto,
Japan) as described previously (Mihailović et al., 2016). The detection
wavelength of PDA was monitored at 260, 280, 325 and 330 nm.
Methanolic solutions of ellagic acid, caffeic acid, gallic acid, vanillic
acid, quercetin, rutin, kaempferol, (+)-catechin, and (−)-epicatechin
were used as reference standards for the identiﬁcation of compounds
in the extracts, which was performed by comparing retention times
and absorption spectra of the peaks with reference standards. The com-
pounds identiﬁed in the extracts were conﬁrmed by spiking the sample
with the standard compound.
2.4. Phytochemical analysis
2.4.1. Total phenolics
The method developed by Singleton et al. (1998) was used to
determine the total phenolic content. 0.5 mL aliquots of the extracts
diluted inmethanol weremixedwith 2.5mL of Folin–Ciocalteu solution
(previously diluted ten-fold with water) and 2 mL of 7.5% aqueous
NaHCO3 solution. The reaction mixture was incubated for 15 min at
45 °C. The absorbance was read at 765 nm. Mass concentrations of
total phenols in plant material were determined using the standard
curve for gallic acid and results were calculated as gallic acid equiva-
lents (mg GAE/g dry weight of extract).
2.4.2. Total ﬂavonoids
The total ﬂavonoid content was estimated by the method of
Quettier-Deleu et al. (2000). The reaction mixture contained 0.5 mL 2%
AlCl3 in methanol and 0.5 mL of extracts solutions in methanol
(1mg/mL). The absorbancewasmeasured at 415 nmafter onehour of in-
cubation at room temperature. Results were calculated as milligrammes
of rutin equivalents per gram of dry weight of extract (mg RUE/g dry
weight of extract).
2.4.3. Phenolic acids
Determination of the total phenolic acids content in plant extracts
was performed according to the method described in the The Polish
Pharmacopoeia VIII (2009), with slight modiﬁcations. Brieﬂy, 1 mL of
plant extracts solutions was added to 5 mL of distilled water, followed
by addition of 1 mL of 0.1 M HCl, 1 mL of Arnow's reagent (10%
Na-molybdate and 10% Na-nitrite), 1 mL of 1 M NaOH, and 1 mL of
distilled water. The absorbance was read immediately at 490 nm.
Results are presented as caffeic acid equivalents (mg CAE/g dry weight
of extract).
2.4.4. Determination of tannins
The method suggested by Scalbert et al. (1989) was used to estimate
the content of condensed tannins in plant extracts. In brief, the extracts
weremixedwith a certain amount of phloroglucinol (for each equivalent
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1mL of 4.8MHCl solution and 1mLof formaldehyde (13mLof 37% form-
aldehyde diluted to 100 mL in water) were added. The reaction mixture
was allowed to stand overnight at room temperature to precipitate the
tannins. Total phenolics were determined in the solution above the pre-
cipitate using Folin–Ciocalteu method and this value was subtracted
from the total phenolics' value to obtain the total tannin content,
expressed as gallic acid equivalents (mg GAE/g dry weight of extract).
The gallotannin content was determined according to the procedure
described by Haslam (1965). To 1.5 mL of a saturated KIO3 solution,
3.5 mL of a methanol solution of the examined extracts were added.
The absorbance of the red intermediate was sprectrophotometrically
determined at 550 nm until the maximum absorbance was reached.
The gallotannin content was determined as gallic acid equivalents
(mg GAE/g dry weight of extract).
2.4.5. Total anthocyanins content
Determination of total and monomeric anthocyanins was conducted
using single pH and pH differential methods (Cheng and Breen, 1991),
based on the ability of anthocyanins to change their structure depending
on the pH. The speciﬁed volume of the samplewasmixedwith pH1.0 KCl
-buffer (0.025M) and pH 4.5 sodium-acetate buffer (0.4M), respectively.
After 30 min incubation, the absorbance was measured spectrophoto-
metrically at 520 and 700 nm. The concentrations of the total and
monomeric anthocyanins were determined as cyanidin-3-glycoside
equivalents according to the following equation: c = (A ∗M ∗ F ∗ 1000) /
(ε ∗ l), where c - concentration of total or monomeric anthocyanins; A -
absorbance of total and monomeric anthocyanins, which is calculated
as (A520-A700)pH 1.0 and (A520-A700)pH 1.0-(A520-A700)pH 4.5, respectively;
M - molar weight of cyanidin-3-glycoside (449.2 g/mol); F - dilution
factor; ε - molar absorptivity (26 900 L/mol ∗ cm); l – cell length (1 cm).
2.5. Antioxidant activity
2.5.1. ABTS·+ radical scavenging activity
Radical scavenging activity against ABTS radical cation (2,2′-azino-bis
(3-ethylbenzothiazoline-6-sulphonic acid))wasmeasured spectrophoto-
metrically following the procedure of Re et al. (1999). The percentage
of ABTS·+ decoloration is proportional to the ability of extract to neu-
tralise radicals and has been calculated using the formula: % inhibition =
((Ac−As) ∗ 100) / Ac,where: Ac – absorbance of the control (methanol
instead of the sample); As – absorbance of the sample.
The concentration of samples providing 50% of radical scavenging ac-
tivity (IC50)was calculated usingdose–response sigmoidal curve plotted
the percentage of inhibition against extract concentration (μg/mL).
2.5.2. DPPH· radical scavenging activity
The ability of plant extracts to neutralise DPPH· radical was esti-
mated according to Kumarasamy et al. (2007). The reaction mixture
containing 1 mL of DPPH· solution in methanol (80 μg/mL) and 1 mL
of each extract solution (serial dilutions in methanol, started from
0.25 mg/mL) was allowed to stand in the dark for 30 min. The absor-
bance was read spectrophotometrically at 517 nm and IC50 values
were calculated.
2.5.3. Hydroxyl radical scavenging activity
OH radical scavenging activity of extracts was determined using the
method performed by Kunchandy and Rao (1990). Brieﬂy, 200 μL of the
extract was mixed with 200 μL of 10 mM iron (III) chloride solution,
followed by 100 μL of 1 mM ascorbic acid solution, 100 μL of 1 mM
EDTA solution, 200 μL of 10 mM 2-deoxy-ribose solution, and 100 μL
of 10 mM hydrogen-peroxide solution. The reaction mixture was incu-
bated at 37 °C for 1 h. Subsequently, 1 mL of TCA-TBA solution (0.5%
TBA in 10% TCA water solution) was added and the ﬁnal mixture was
incubated at 80 °C for 30 min and cooled to room temperature. The
absorbance of the cooled reaction mixtures was measured at 535 nm.On the basis of the obtained absorbance values, the percentage of
inhibition and IC50 values were calculated.
2.5.4. Estimation of metal chelating ability
The assessment of ability of plant extracts to inhibit the formation of
Fe2+-ferrozine complex was carried out according to the method by
Chew et al. (2009). Onemililitre of 0.125mM iron (II) sulphate solution
and 1 mL of 0.3125 mM ferrozine water solution were added to 1 mL of
serial dilutions of extracts dissolved in methanol. The reaction mixture
then allows standing at room temperature for 10 min. The IC50 values
were determined after reading the absorbance at 562 nm.
2.5.5. Reducing power
According to the method of Oyaizu (1986), to 2.5 mL of extracts
solutions in methanol (0.5 mg/mL), 2.5 mL of sodium-phosphate buffer
(0.2 M, pH 6.6) and 2.5 mL of 1% potassium ferricyanide were added.
The reaction mixture was left to stand for 20 min at 50 °C, followed by
addition of 2.5 mL of 10% TCA. In 5 mL of this solution, 1 mL of 1% iron
(III) chloride solution was added and absorbance was read promptly at
700 nm. Trolox, as a referent antioxidant, was used for the construction
of calibration curve and the results of reducing capacity of tested extracts
were expressed as Trolox equivalents (mg TE/g dry weight of extract).
2.5.6. Total antioxidant activity
Prieto et al. (1999) developed a method for the determination of
the total antioxidant activity of plant extracts. In brief, 0.3 mL of the
extracts dissolved in methanol was mixed with 3 mL of reagent solu-
tion (0.6M sulphuric acid, 28mMsodiumphosphate, 4mMammonium
molybdate) and incubated for 90 min at 95 °C. Then, the reaction
mixture was cooled to room temperature and the absorbance of the
green-phosphate/Mo (V) complex was monitored at 695 nm. The
results are expressed as mg ascorbic acid (AA) per gram of dry extract,
using a standard curve for ascorbic acid.
2.5.7. Oil-in-water emulsion
Inhibitory activity of AVA and AVR towards lipid peroxidation was
performed according to the procedure described by Hsu et al. (2008).
To 0.5 mL of the serial dilutions of the extracts in methanol, 2.5 mL of
linoleic acid emulsion (0.2804 g of linoleic acid and 0.2804 g of
Tween-40 in 50 mL of 40 mM sodium phosphate buffer pH 7.0) was
added. The emulsion was incubated for 72 h at 37 °C. Thereafter,
0.1 mL of this solution was mixed with 4.7 mL of ethanol, 0.1 mL of
30% ammonium thiocyanate solution, and 0.1 mL of 20 mM iron (II)
chloride solution. Subsequently, the mixture was stirred for 3 min
and afterwards the absorbance was read spectrophotometrically at
500 nm against the methanol (blank).
2.6. Antimicrobial activity
2.6.1. Test microorganisms
The antimicrobial properties of A. vulgaris were tested against nine
bacterial and ten fungal strains. The employed bacteria were as follows:
Micrococcus lysodeikticus (ATCC 4698), Enterococcus faecalis (ATCC
29212), Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC
70063), Pseudomonas aeruginosa (ATCC 10145), Salmonella typhimurium
(ATCC 14028), Bacillus subtilis (ATCC 6633), and isolated strains
from biological samples Bacillus mycoides (FSB 1) and Azotobacter
chroococcum (FSB 14). Antifungal activity was evaluated against ATCC
cultures of Aspergillus brasiliensis (ATCC 16404) and yeast Candida
albicans (ATCC 10259), whereas following fungi were isolated from bio-
logical samples: Phialophora fastigiata (FSB 81), Penicillium canescens
(FSB 24), Trichoderma viride (FSB 11), Trichoderma longibrachiatum
(FSB 13), Aspergillus glaucus (FSB 32), Fusarium oxysporum (FSB 91),
Alternaria alternata (FSB 51), and Doratomyces stemonitis (FSB 41). The
isolates of the bacteria and fungi were obtained from the Laboratory
for Microbiology, Faculty of Science, University of Kragujevac, Serbia.
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Kragujevac, Serbia.The bacteria and fungi cultures were subcultured
prior to testing; bacterial strains were cultured for 24 h at 37 °C on nutri-
ent agar (NA), C. albicans was cultured on Sabouraud dextrose broth
(SDB) for 24 h at 35 °C, whereas fungi were grown on potato glucose
agar (PDA).
2.6.2. Microdilution method
Microdilution method described by Sarker et al. (2007) was
employed to evaluate the antimicrobial activity of the samples, with
some modiﬁcations. Brieﬂy, overnight-cultured bacterial cultures were
suspended in small amount of 5% DMSO than adjusted to the 0.5
McFarland turbidity standard using sterile normal saline and diluted to
obtain inoculum concentration of 5 ×106 CFU/mL for brothmicrodilution
MIC testing (CLSI, 2012). The analysed extracts (40 mg/mL), ellagic acid
and catechin (1 mg/mL) and antibiotic erythromycin (40 μg/mL) were
also dissolved in 5% DMSO. Determination of minimum inhibitory con-
centrations (MIC) of extracts for bacteria was performed in sterile 96
well plates (Spektar, Čačak, Serbia). 50 μL of two-fold serial diluted
extracts inMuller-Hinton broth (MHB) was added to eachwell, followed
by addition of 10 μL of resazurin (indicator), 30 μL of MHB, and 10 μL of
bacteria suspension. The ﬁnal bacterial concentration of in each well
was 5 × 105 CFU/mL (CLSI, 2012). Each plate also included positive
(erythromycin at a concentration range 20–0.156 μg/mL), growth
(MHB, resazurin, and bacteria suspension) and sterility (MHB and
resazurin, without bacteria suspension) controls. The microplates were
incubated for 24 h at 37 °C. The lowest concentration of the extracts
containing blue-purple indicator's colour was considered as MIC.
Fungal species were cultured on PDA at 28 °C from 48 h to 5 days.
Obtained colonies covered with a small volume of 5% DMSO to obtain
the suspension, and then a ﬁnal concentration of inoculum suspension
was adjustedwith sterile normal saline to 5× 104 CFU/mL in accordance
with NCCLS recommendation (NCCLS, 2002a, 2002b). The concentra-
tion of the extracts was 40 mg/mL, 40 μg/mL for antimycotic nystatin,
and 2 mg/mL for ellagic acid and catechin. MICs for fungal species
were also determined in sterile 96 well plates (NCCLS, 2002a, 2002b).
50 μL of serially diluted extracts in SDB, 40 μL of SDB, and 10 μL of fungal
suspension were added to each well, whereupon microplates were
incubated at 28 °C for 48h.MICswere determined as the lowest concen-
tration of extracts without visible fungal growth.
2.7. Evaluation of anti-inﬂammatory activity
2.7.1. COX-1 and COX-2 in vitro assays
The inhibition of COX-1 and COX-2 enzymes were evaluated using
in vitro assays in a 96-well plate with prostaglandin H synthase
(PGHS)-1 from ramseminal vesicles for COX-1 and human recombinant
PGHS-2 for COX-2 as previously described (Fiebich et al., 2005) with
modiﬁcations published by Katanić et al. (2016). Brieﬂy, 10 μL of
extracts (50 μg/mL) dissolved in DMSO were added to the incubation
mixture containing 180 μL of 0.1 M TRIS/HCl-buffer (pH 8.0), 5 μM
hematin, 18 mM epinephrine hydrogen tartarate, 0.2 U enzyme
preparation and 50 μM Na2EDTA (only for COX-2 assay) and allowed
to stand for 5 min. Positive controls, indomethacin (1.25 μM, for
COX-1) and NS-398 (5 μM, for COX-2) were also dissolved in DMSO.
To start the reaction, 10 μL of 5 μM arachidonic acid in ethanol wasTable 1
Total phenolic compounds in methanolic extracts of aerial parts and roots of A. vulgaris.
mg GAEs/g d.w. mg RU
Plant extracts Total phenolics Condensed tannins Gallotannins Total
AVA 558.19 ± 4.83a 386.70 ± 6.82c 97.98 ± 0.01e 13.30
AVR 442.32 ± 22.31b 360.88 ± 2.17d n.d. 19.80
Results are expressed as mean values ± SD from three measurements; GAEs – gallic acid equiv
glycoside equivalents per gram of dry weight of extract; n.d. – not detected; means with differadded to the reaction mixture. After 20 min of incubation at 37 °C, the
reaction was terminated by adding 10 μL of 10% formic acid.
The competitive PGE2 EIA kit was applied for the determination of
the PGE2, the main arachidonic acid metabolite in this reaction. The
microplate reader (Tecan Rainbow, Switzerland) was used for evalua-
tion of EIA and the PGE2 concentration was determined according to
the method described by Fiebich et al. (2005). All experiments were
performed in at least three independent experiments run in duplicate.
Inhibition of COX refers to the reduction of PGE2 formation in compari-
son to a blank without inhibitor.
2.7.2. COX-2 gene expression assay
COX-2 gene expression analysis was performed in accordance with
the previously described method (Livak and Schmittgen, 2001) and
with slight modiﬁcations described in Katanić et al. (2016). The differen-
tiated human leukemic monocytic cell line THP-1 were treated with
plant extracts (25 μg/mL) for 1 h and stimulated with 7.5 ng/mL ﬁnal
concentration LPS (lipopolysaccharide). Cells treated with DMSO
(dimethylsulfoxide ⩽ 0.1%) were used as calibrator sample.
2.8. Biocompatibility of extracts
BalbC-3 T3 ﬁbroblasts and human epidermal keratinocytes were
cultured in Dulbecco's Modiﬁed Eagle's Medium, supplemented with
10% fetal bovine serum, 2mML-glutamine and antibiotics (streptomycin
and penicillin) in a 5% CO2 humidiﬁed atmosphere at 37 °C.
For biocompatibility experiments, cells were seeded in 96-well plates
at a density of 2 × 103/well (HaCaT cells) and 3 × 103/well (BalbC-3 T3
cells). 24 h after seeding, increasing concentrations of the extracts (from
10 to 50 μg/mL) were added to the cells. After 48 and 72 h incubation,
cell viability was assessed by the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay, as described by Del Giudice
et al. (2015). Cell survival was expressed as the percentage of viable
cells in the presence of the extract compared to controls. Two groups of
cells were used as a control, i.e. cells untreated with the extract and cells
supplemented with identical volumes of buffer. The average of the two
control groups was used as 100%. Each sample was tested in three inde-
pendent analyses, each carried out in triplicates.
2.9. Statistical analysis
The standard deviation was calculated using Microsoft Ofﬁce Excel
2007 software and all results were expressed as mean values ± SD.
Statistical analysis of the results was performed by one-way analysis
of variance (ANOVA) using theOriginPro8 software package (OriginLab,
Northampton, Massachusetts, USA) forWindows. The statistical signiﬁ-
cance was set at p b 0.05.
3. Results
3.1. Phytochemical results
We analysed the total phenolic compounds by spectrophotometry
and HPLC-PDA to identify major phenolic components in the A. vulgaris
extracts. Our results of the analysis of phenolic compounds inmethanolic
extracts of aerial parts and roots of A. vulgaris revealed a high content inEs/g mg CAEs/g mg C3Gs/g
ﬂavonoids Phenolic acids Total anthocyanins Monomeric anthocyanins
± 1.69f,g 33.43 ± 1.15h 8.41 ± 0.17f,g,j 8.00 ± 0.18f,j
± 0.35g 57.36 ± 5.18i 1.36 ± 0.06j 0.95 ± 0.07j
alents, RUEs – rutin equivalents, CAEs – caffeic acid equivalents, and C3Gs – cyanidine-3-
ent symbol in superscript are signiﬁcantly different at p b 0.05.
Fig. 1. HPLC-PDA chromatogram of A. vulgarismethanolic extract of aerial parts (A) and roots (B) recorded at 280 nm with tentatively identiﬁed ellagic acid (1) and (+)-catechin (2).
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mination demonstrated signiﬁcantly higher (p b 0.05) amount of total
phenolics in AVA (558.27 mg GAEs/g) in comparison with AVR
(442.32 mg GAEs/g). The most dominant phenolics in AVA were con-
densed tannins (proanthocyanidins) and gallotannins (386.70 and
97.80 mg GAEs/g), while AVR contained a slightly lower amount of con-
densed tannins (360.88 mg GAEs/g) and no detectable amount of
gallotanins. On the contrary, the concentration of hydroxycinnamic
acids derivatives was found to be signiﬁcantly higher in the roots of
A. vulgaris, while no signiﬁcant difference in the content of ﬂavonoids
was observed. Anthocyanins content in the root extract was signiﬁcantly
lower (p b 0.05)when compared to all other examined classes of pheno-
lic compounds. Fig. 1 presents HPLC-PDA chromatograms of AVA and
AVR. Two of the peaks were tentatively identiﬁed as ellagic acid in the
above ground parts and (+)-catechin in the roots extract by matching
their retention times and comparing their UV-spectra at 260, 280, 325
and 330 nm. The identiﬁed compounds in the extracts were also con-
ﬁrmed by spiking the extracts with reference compounds.Table 3
Antibacterial activity of methanolic extracts of aerial parts and roots of A. vulgaris.
Bacterial species MIC valuesa
AVA AVR
Micrococcus lysodeikticus (ATCC 4698) 0.156 0.156
Salmonella typhimurium (ATCC 14028) 0.625 0.625
Bacillus subtilis (ATCC 6633) 2.5 1.25
Enterococcus faecalis (ATCC 29212) 0.625 0.156
Escherichia coli (ATCC 25922) 1.25 1.25
Klebsiella pneumoniae (ATCC 70063) 5 10
Pseudomonas aeruginosa (ATCC 10145) 2.5 5
Bacillus mycoides (FSB 1) 0.625 0.156
Azotobacter chroococcum (FSB 14) 5 2.5
a MIC values, minimum inhibitory concentrations given as mg/mL for plant extracts, ellagic
Table 2
Antioxidant capacity of the A. vulgaris aerial parts and roots methanolic extracts and standards
Plant extracts and standards IC50 value (μg/mL)
Radical scavenging activity I
DPPH• ABTS+ •OH O
AVA 5.96 ± 0.21a 14.80 ± 2.15a 13.06 ± 0.97a 3
AVR 11.86 ± 0.56b 32.49 ± 1.95b 18.44 ± 1.11b 4
BHT 26.25 ± 1.9c 44.67 ± 3.00c 21.93 ± 0.47c 4
Catechin 7.52 ± 0.04a 5.97 ± 0.16d 6.32 ± 0.33e 6
Ellagic acid 3.54 ± 0.13d 8.14 ± 0.18d 7.18 ± 0.89e 1
AA – ascorbic acid; means in the same column with different symbol in superscript are signiﬁc3.2. Antioxidant activity
Because of the drawbacks of the individual use of any in vitromethod
for evaluation of antioxidant activity, several methods for screening the
antioxidant potential of AVA and AVR have been employed and the re-
sults are reported in Table 2. The absorbance of green phosphate/Mo
(V) complex formed at acidic pHwasmeasured to evaluate the total an-
tioxidant activity of the extracts. The obtained results showed that AVR
exerts a higher total antioxidant activity than AVA (316.5 and 265.6 mg
ascorbic acid/g, respectively). The potential ability of the extracts to
neutralise free radicals was investigated using DPPH·, ABTS·+, and
·OH assays. In these assays, AVA showed better antiradical activity
with signiﬁcantly lower (p b 0.05) IC50 values than AVR. Considering
the reference antioxidants, AVA and AVR could scavenge DPPH·,
ABTS·+, and ·OH radicals at signiﬁcantly lower (p b 0.05) concentra-
tions than the synthetic antioxidant butylated hydroxytoluene (BHT).
Furthermore, there was no statistically signiﬁcant difference in DPPH·
radical scavenging activities betweenAVA and thewell-knownphenolicEllagic acid Catechin Erythromycin
0.5 N1 20
0.5 0.5 20
0.25 0.5 10
0.031 N1 1.25
N1 N1 5
N1 N1 N20
1 1 20
0.016 N1 1.25
0.031 N1 20
acid, and catechin, and as μg/mL for antibiotic erythromycin.
: BHT, catechin, and ellagic acid.
Total antioxidant
activity
(mg AA/g of extract)
Reducing capacity
(mg Trolox/g of extract)
nhibition of lipid peroxidation
il-in-water system
1.91 ± 3.12a 265.62 ± 12.10 632.99 ± 10.26
75.13 ± 11.41b 316.47 ± 18.71 607.52 ± 10.01
.53 ± 0.07c n.t. n.t.
.63 ± 0.11c n.t. n.t.
0.87 ± 0.50c n.t. n.t.
antly different at p b 0.05.
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activity between the two extracts was also observed in an oil-in-water
system, where AVR showed almost ﬁfty times higher IC50 value than
AVA (475.1 and 31.9 μg/mL, respectively). Quite similar results for
AVA and AVR were obtained in the reducing power assay (633.0 and
607.5 mg Trolox/g, respectively).
The ferrous ion chelating testwas employed to estimate the ability of
the extracts to chelate transition metals and to avoid the iron-overload
and generation of free radicals. All tested samples failed to chelate Fe2+
at concentration 1 mg/mL.3.3. Antimicrobial activity
The results obtained for antimicrobial activity are shown in Tables 3
and 4. Enterococcus faecalis, Salmonella typhimurium, Micrococcus
lysodeikticus, and Bacilus mycoides were the most sensitive examined
bacterial species to the tested A. vulgaris extracts, with MICs between
0.156 and 0.625 mg/mL. On the contrary, Klebsiella pneumoniae was
the most resistant bacteria in our study (MIC = 5 mg/mL for AVA and
10 mg/mL for AVR). MICs values above 1 mg/mL for AVA and AVR
were also observed for Pseudomonas aeruginosa, Bacillus subtilis,
Azotobacter chroococcum, and Escherichia coli. Ellagic acid and catechin
were used as reference compounds. Catechin failed to inhibit the
growth of all tested bacteria at concentrations lower than 0.5 mg/mL.
We observed that ellagic acid has antibacterial potential against the
same bacteria as the extracts, but MICs obtained for it were lower
than those for the extracts for the majority of bacteria. The commer-
cially available antibiotic erythromycin was more active against all
tested bacteria than the investigated extracts, ellagic acid, and catechin,
with MICs ranging from 1.25 to 20 μg/mL.
The investigated extracts showed similar activity againstmost of the
tested fungi, with MICs from 2.5 to above 20 mg/mL (Table 4). AVA and
AVR exhibited negligible antifungal activity against Doratomyces
stemonitis (2.5 and 5 mg/mL, respectively) and Aspergillus glaucus (5
and 10 mg/mL, respectively). On the contrary, AVA failed to inhibit
both Trichoderma species, while AVR did not show any antifungal effect
against Aspergillus brasiliensis and Alternaria alternata at a concentration
of 20mg/mL.Moreover, both extracts did not inhibit the growth of Can-
dida albicans at the highest tested concentration. Ellagic acid failed to in-
hibit the growth of the majority of the employed fungi at a
concentration lower than 1 mg/mL, except for P. canescens (MIC =
0.25 mg/mL), while catechin did not exhibit any antifungal activity at
the same concentration. Our results showed the lower activity of AVA,
AVR, and reference compounds against all tested fungi in comparison
with the antimycotic nystatin, which has demonstrated antifungal
activity at concentrations from 0.078 up to 5 μg/mL.Table 4
Antifungal activity of the methanolic extracts of aerial parts and roots of A. vulgaris.
Fungal species MICa values
AVA AVR Ellagic
acid
Catechin Nystatin
Phialophora fastigiata (FSB 81) 10 20 N1 N1 1.25
Penicillium canescens (FSB 24) 20 20 0.25 N1 2.5
Trichoderma viride (FSB 11) N20 20 1 N1 0.078
Trichoderma longibrachiatum
(FSB 13)
N20 20 N1 N1 0.078
Aspergillus brasiliensis
(ATCC 16404)
20 N20 N1 N1 5
Aspergillus glaucus (FSB 32) 5 10 1 N1 5
Fusarium oxysporum (FSB 91) 10 20 1 N1 2.5
Alternaria alternata (FSB 51) 20 N20 N1 N1 0.625
Doratomyces stemonitis (FSB 41) 2.5 5 N1 N1 2.5
Candida albicans (ATCC 10259) N20 N20 N1 N1 0.625
a MIC values, minimum inhibitory concentrations given as mg/mL for plant extracts,
ellagic acid, and catechin, and as μg/mL for antimycotic nystatin.3.4. Anti-inﬂammatory activity
Fig. 2. represents results of COX-1 and COX-2 inhibition assays as
well as COX-2 gene expression. Our results revealed that at a concentra-
tion of 50 μg/mL, AVA was capable of inhibiting the activity of COX-1
enzyme by 44.4%, whereas the inhibition of COX-2 was higher
(63.6%). Similar results were observed for AVR (44.1% for COX-1 and
40.4% for COX-2). The tested extracts at a concentration of 25 μg/mL
did not inhibit COX-2 gene expression.
3.5. Biocompatibility results
Finally,we analysed thebiocompatibility of the extracts byperforming
a cell survival assay. The extracts were tested on immortalised murine
BalbC-3 T3 ﬁbroblasts and human normal HaCaT keratinocytes in a
dose- and time-response test. As shown in Fig. 3, no signiﬁcant differences
in cell survival between control group and groups treated with extracts
were observed. Indeed, both extracts showed total biocompatibility
with the two cell lines after 48 and 72 h.
4. Discussion
Notwithstanding that species from genus Alchemilla have been used
for many years in traditional medicine and are widely spread across
Europe, only a few reports have focused on their chemical composition
analysis. We tentatively identiﬁed ellagic acid in AVA and (+)-catechin
in AVR by HPLC-PDA analysis. Our results supported previously
published research, which indicated that ellagic acid is the major
phenolic component in the aerial parts of A. vulgaris (Møller et al.,
2009; Neagu et al., 2015; Ilić-Stojanović et al., 2017). To the best of
our knowledge, phytochemical screening of A. vulgaris underground
partswas performed only byGeiger et al. (1994). They found condensed
tannins as major components (50% of the total tannins) of the 80%
methanolic extract of A. vulgaris roots and conﬁrmed the presence of
ellagitannins (agrimoniin, pedunculagin, and laevigatin F) in the fresh
aerial and underground parts as well. By spectrophotometric determi-
nation, we observed a high amount of phenolic compounds in both ex-
tracts; the extracts were especially rich in condensed tannins. Maier
et al. (2017) found that the Lady's mantle herb extract contains about
30% w/w of tannins, which is in agreement with our ﬁndings. Ellagic
acid manifests a broad spectrum of biological activity (Khanduja et al.,
1999; Beserra et al., 2011). With regard to the high amount of phenolic
compoundswith proven health beneﬁts,A. vulgaris can be considered as
a promising medicinal plant.
Free radicals and other oxidants are responsible for the emergence
of a large number of diseases, such as Parkinson's disease, cancer,
cardiovascular, and obesity-related diseases (Lobo et al., 2010). There
is increasing evidence that phenolics and other natural antioxidants
from plants in the human diet may prevent, postpone and control the
development of degenerative diseases (Consolini and Sarubbio, 2002;
Dastmalchi et al., 2012; Costa et al., 2013; Batista et al., 2014).
The results we obtained for antioxidant activity of examined extracts
through seven methods undoubtedly demonstrated the strong
antioxidant potential of extracts, comparable with reference compound
catechin and even better than synthetic preservative (BHT) in certain
antioxidant assays. AVA showed signiﬁcantly better (p b 0.05)
antioxidant activities in all employed methods in our study, except for
total antioxidant activity. Furthermore, AVA demonstrated particularly
better antioxidant activity in the inhibition of lipid peroxidation than
AVR. The lowest IC50 values for the extracts were recorded in DPPH
assay. IC50 values for the extracts were lower in comparison with
those for BHT and they are in common with the results reported by
Ilić-Stojanović et al. (2017), while no statistically signiﬁcant difference
(p b 0.05) was observed between AVA and catechin. Since numerous
plant phenolics have been found to be responsible for biological proper-
ties, it can be assumed that antioxidant activities of these extracts are
Fig. 2.COX-1 and COX-2 inhibitory activities and COX-2 gene expression on THP-1 of A. vulgaris extracts (50 and 25 μg/mL, respectively). Indomethacin,NS-398 anddexamethasone (DEX)
were used as positive controls, according to Katanić et al. (2016). The graph represents compiled data (% inhibition) of two independent experiments (mean ± SD).
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polyphenols, strong antioxidant activity under in vitro and in vivo condi-
tions was reported for other species from the Rosaceae family (Katanić
et al., 2015; Jiménez-Aspee et al., 2016).
One of themain reasons to ﬁndnovel natural sources of antioxidants
is the fact that a large number of reactive oxygen species is produced
during the inﬂammatory process (Conner and Grisham, 1996). Seriousside effects of existing anti-inﬂammatory drugs are burning pharma-
ceutical concern worldwide. Therefore, research goes on to ﬁnd new
highly effective and harmless anti-inﬂammatory remedies of natural
origin which can be alternatives to NSAID’s. The undertaken study
demonstrates, for the ﬁrst time, the effects of A. vulgaris methanolic
extracts on COX-1 and COX-2 enzymes inhibition, with the preferential
COX-2 inhibitory activity of AVA with AVR approximately the same
Fig. 3. Effects of A. vulgaris aboveground parts (A) and roots (B)methanol extracts on the viability of mouse immortalised BalbC-3 T3 ﬁbroblasts and human normal HaCaT keratinocytes.
Dose- and time-response curves of cells after 48 h (black bars) and 72h (grey bars) incubation in the presence of increasing concentrations of the extracts. Cell viabilitywas assessed by the
MTT assay; the cell survival percentage was deﬁned as described in Materials and Methods section. Values are given as means ± S.D. (n ≥ 3).
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not COX-2 speciﬁc, the relatively high percentage of the inhibition of
COX enzymes is conﬁrming the presence of anti-inﬂammatory com-
pounds in this extract. Therefore, these results can be of great impor-
tance for further testing of Lady's mantle as a potential anti-
inﬂammatory remedy. NF-κB is a nuclear transcription factor regulating
the expression of various genes, including IL-1β, IL-6, TNF-α, and iNOS,
which play critical roles in inﬂammation, apoptosis, and tumour genesis
(Lawrence et al., 2001). Negative results obtained for NF-κB production
in our study indicate that neither AVA nor AVR exert their anti-
inﬂammatory activity through the inhibition of NF-κB. Anti-
inﬂammatory activity of A. vulgaris has already been tested for the in-
hibition of 15-lipoxygenase activity (Trouillas et al., 2003), and the re-
sults provided a presumption that anti-inﬂammatory action of
A. vulgaris may be related to the inhibitory activity of phenolic com-
pounds on arachidonic acid metabolism through the lipoxygenase path-
way. According to Şeker-Karatoprak et al. (2017), methanolic and water
extracts of A. mollis decreased the nitrite as well as inhibited TNF-α pro-
duction in LPS-induced macrophages. In support of the traditional use of
Alchemilla species in wound treatment, Shrivastava et al. (2007)
displayed acceleration in wound healing and a signiﬁcant reduction in
the size of dorsal skin lesions in rats by the second day of the treatment
with 3% A. vulgaris in glycerine. Also, A. vulgaris enhanced proliferation
of epithelial, liver and myoﬁbroblasts cells as well. It is worth noting
that no cytotoxic effect or any morphological changes were observed in
the cells exposed to A. vulgaris extract in the above mentioned study.
We obtained the same results in our study through biocompatibility as-
says on immortalised ﬁbroblasts BalbC-3 T3 and normal epidermal
HaCaT cells during 48 and 72 h. Fibroblasts and keratinocytes facilitate
the protective role of normal skin andplay a crucial role in cutaneous rep-
aration process. When a wound occurs, then natural skin barrier is
disrupted, which promotes the proliferation as well as the maturationof ﬁbroblasts and keratinocytes. They migrate into the wound site and
communicate via certain signalling loops, which support the restoration
and regeneration of tissue homeostasis after wounding (Wojtowicz
et al., 2014). Biocompatibility of plant extracts may prevent differentia-
tion, proliferation, and attaching of these skin cells. The results of our
study indicate that the application of AVA and AVR at doses ranging
from 10 to 50 μg/mL provides good biocompatibility, with no toxic
or injurious effects on the healthy cells.
According to Kuete (2010), an extract can be considered as a potent
antibacterial agent with signiﬁcant antibacterial activity with MICs
below 0.1mg/mL, whileMICs between 0.1 and 0.625 pointed tomoder-
ate activity against bacterial growth. MICs above 0.625 mg/mL referred
to weak activity. The results in Table 3 revealed that Gram-positive
bacteria are more susceptible in comparison with Gram (−) ones.
These ﬁndings are not surprising, considering the fact that Gram (−)
bacteria are more resistant than Gram (+) ones to plant extract treat-
ment, because of the porins and lipopolysaccharides present in their
outer membrane, which provides a protective barrier and prevents in-
tracellular penetration of antibiotics, especially lipophilic ones
(Apetrei et al., 2011). To the extent of our knowledge, this is the ﬁrst
study covering antimicrobial activity of Alchemilla roots. Additionally,
there are no literature data related to the antifungal activity of
Alchemilla species, while only a few scientiﬁc reports provide informa-
tion about activities of the aboveground parts of Alchemilla species
against bacteria and C. albicans. Our results displayed negligible antifun-
gal activity of A. vulgariswithMICs from 2.5 to above 20mg/mL. Our re-
sults are in accordance with the results published by Keskin et al.
(2010), indicated that ethanol extract of A. vulgaris at a concentration
of 4 mg/mL exhibited moderate antibacterial activity against ten bacte-
rial species, whereby themost sensitive oneswereGram-positive bacte-
ria, including E. faecalis. Krivokuća et al. (2015) reported that extracts of
four Alchemilla species exerted anti-Helicobacter pylori effect with MICs
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as for AVR and AVA has been observed for ellagic acid, where the most
sensitive strains were Gram positive bacteria M. lysodeikticus,
E. faecalis, and B. mycoides and Gram negative – A. chrococcum. Our re-
sults showed low susceptibility of tested bacteria to catechin. Antibacte-
rial effects of A. vulgarismay be attributed to the high content of tannins
presented in the extracts (Djipa et al., 2000). With respect to the results
of antibacterial activity of phenolic standards, our ﬁndings indicate that
use of A. vulgaris extracts may bemore beneﬁcial than the application of
individual compounds, due to the possible synergistic effects of the
other components of the extracts.
5. Conclusion
Our results have demonstrated that methanolic extracts of aerial
parts and roots of A. vulgaris are rich in phenolic compounds.
Through the evaluation of antioxidant, antibacterial, antifungal, and
anti-inﬂammatory activities, we observed the remarkable biological ac-
tivity of the tested extracts, as well as their full biocompatibility with ﬁ-
broblasts and keratinocytes. Taking into account promising biological
activity and safety of A. vulgaris, our further research will be aimed to
investigate its biological activities under in vivo conditions. We hope
to discover the potential mechanism of biological action and to eluci-
date whether the speciﬁc biological activity is a result of the activity of
individual components or synergistic action of several constituents.
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